Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials. [electronic resource]
Producer: 20170109Description: 401-7 p. digitalISSN:- 1365-4632
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Double-Blind Method
- Female
- Humans
- Immunologic Factors -- therapeutic use
- Male
- Middle Aged
- Pain -- etiology
- Patient Reported Outcome Measures
- Pruritus -- etiology
- Psoriasis -- complications
- Severity of Illness Index
- Symptom Assessment
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.